Case Report: Contrast-enhanced ultrasonography for evaluating a newly detected contralateral pulmonary lesion during non-small cell lung cancer chemoimmunotherapy - Top-Institutions - MDSpire

Case Report: Contrast-enhanced ultrasonography for evaluating a newly detected contralateral pulmonary lesion during non-small cell lung cancer chemoimmunotherapy

  • By

  • Yang Liu

  • Lusi Feng

  • Xiaoqian Yang

  • Shiyu Wen

  • Yu Xiang

  • Xuelei Ma

  • Rongxing Zhou

  • Wei Du

  • May 21, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    our institution
    our institution

    Unknown, Unknown

    Key Differentiators

    • Radiology

  • #2

    Trinity St. James’s Cancer Institute
    Trinity St. James’s Cancer Institute

    Dublin, Ireland

    Key Differentiators

    • Oncology

  • #3

    another hospital
    another hospital

    Unknown, Unknown

    Key Differentiators

    • General Hospital

  • #4

    Vanderbilt University Medical Center
    Vanderbilt University Medical Center

    Nashville, Tennessee

    Key Differentiators

    • Oncology
    • Radiology

  • #5

    American College of Surgeons Oncology Group
    American College of Surgeons Oncology Group

    Unknown, Unknown

    Key Differentiators

    • Surgery
    • Oncology

Original Source(s)

Case Report: Contrast-enhanced ultrasonography for evaluating a newly detected contralateral pulmonary lesion during non-small cell lung cancer chemoimmunotherapy

  • by Yang Liu, Lusi Feng, Xiaoqian Yang, Shiyu Wen, Yu Xiang, Xuelei Ma, Rongxing Zhou, Wei Du

  • May 21, 2026

Related Content

Turning Medical Insights into Patient Impact

Veeva research reveals a stark gap between the insights biopharma captures and the actions it takes – highlighting a missed opportunity to improve patient outcomes

Rethinking Progress in Clinical Trials

Three clinical development leaders discuss how early signals, trial design, regulatory expectations, and patient access are reshaping clinical development

  • May 20, 2026

  • 11 min
Roswell Park Experts Report on Discovery of Rare Bladder Cells, Neural Mapping of Pelvic Floor Muscles at AUA 2026

Evidence provided by a Roswell Park study indicates that neoadjuvant chemotherapy may be the preferred course of treatment for patients with non-muscle-invasive bladder cancer (NMIBC) when their disease progresses and they are diagnosed with muscle-invasive bladder cancer (MIBC)

  • by

  • May 19, 2026

  • 7 min